Related Experiment Video
Updated: Jan 1, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Refractory recurrent ocular graft versus host disease.
Emily Greenan1,2, Elisabeth Vandenberghe3, Conor C Murphy4,2
1Ophthalmology, Royal College of Surgeons in Ireland, Dublin, Ireland.
Ocular graft-versus-host disease (GVHD) is a common complication after stem cell transplants, often causing severe eye problems. Current treatments are unsatisfactory, highlighting the need for better management strategies for this debilitating condition.
Area of Science:
- Hematology
- Ophthalmology
- Transplantation Medicine
Background:
- Ocular graft-versus-host disease (GVHD) is a frequent long-term complication following hematopoietic stem cell transplantation.
- It significantly impacts patient morbidity and quality of life.
Observation:
- There is a lack of established management guidelines and satisfactory treatment regimens for ocular GVHD.
- Prophylactic strategies are underdeveloped, with treatment often commencing after irreversible ocular damage.
Findings:
- This report details a case of recurrent ocular GVHD with complications.
- The condition proved highly refractory to existing treatment approaches.
Implications:
- The case underscores the challenges in managing refractory ocular GVHD.
- Further research is needed to develop effective prophylactic and therapeutic strategies for ocular GVHD.
More Related Videos
07:37Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model
Published on: January 26, 2024
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment